Position in OSTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$69,684
+$17,971 QoQ
Shares Held
36,676
0.0% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 29 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OSTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026INGALLS & SNYDER LLC holds $733,965,925 across 13 Biotechnology names. OSTX ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
7,934,507 | $689,905,383 | |
| 2 | OMER |
Omeros Corp
|
3,659,523 | $34,802,063 | |
| 3 | HYFT |
MindWalk Holdings Corp.
|
3,035,479 | $4,796,056 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,903 | $1,442,007 | |
| 5 | GMAB |
Genmab A/S
|
50,841 | $1,396,602 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
7,339 | $574,423 | |
| 7 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
68,450 | $452,454 | |
| 8 | VCEL |
Vericel Corp
|
5,000 | $222,450 |
All Filings in OSTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,684 | 36,676 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $51,713 | 36,676 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $51,346 | 36,676 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $71,884 | 36,676 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $68,950 | 36,676 | Shares | Other | 2025-07-31 | |
| 2025-03-31 | $56,481 | 36,676 | Shares | Other | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||